CALR and neoplasm: Tumor-bearing mice vaccinated with pcDNA3-CRT/LT had the best survival (Figure5B), suggesting that pcDNA3-CRT/L T DNA vaccine can produce therapeutic antitumor effects against LT-expressing tumors.